HeartBeam Reveals Data Depicting the Use of HeartBeam AI in Addition with VCG for Detecting Arrhythmias
Shots:
- HeartBeam has highlighted data from the study using HeartBeam AI with vectorcardiography (VCG) vs single-lead ECGs to detect atrial flutter at the European Heart Rhythm Association (EHRA) conference
- The study demonstrated an improvement of 28% in identifying atrial flutter cases with a sensitivity of 91.0% with VCG vs 71.2% with single-lead ECG. It showed a specificity of 98.7% vs 96.9% in the identification of individuals with or without atrial flutter
- The company’s 3D VECG technology, for remote cardiac monitoring, works by capturing heart signals through X, Y & Z projections to synthesize 12-lead ECG. Its 1st application will be in HeartBeam AIMIGo which is currently under the US FDA’s review
Ref: HeartBeam | Image: HeartBeam
Related News:- HeartBeam Enrolls First Patients for the Clinical Evaluation of AIMIGo System for Arrhythmia Detection
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
